Login

Gianmarco Orgnoni, COO of Vection Technologies (ASX: VR1), joins ASX Investor Channel to discuss company developments and strategies. 00:10:00

Share On Facebook Share On Twitter

Gianmarco Biagi is the CEO of Vection Technologies.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Adventure Box CEO Christopher Kingdon Discusses Q2 Performance and Strategic Plans | Christopher Kingdon, CEO, Adventure Box Technology AB.
00:10:00
Market Update & Insights | RYAN PARKER - CEO of EP Wealth Advisors
00:10:00
Cerrado Gold Eyes Massive Growth: Projecting $488 Million in Free Cash Flow by 2030|Mark Brennan,CEO,Cerrado Gold
00:10:00
We are focus on areas where customer acquisition is particularly difficult: consumer, gaming, marketplaces|Ben Mathews,General Partner, Night Ventures
00:10:00
Epiroc and Fordia Launch 'One Face of Exploration' to Streamline Service and Products
00:00:00
Lily C. Wong-Kisiel, M.D. Neurologist, Mayo Clinic
00:10:00
Ravi BT, GM - Sales & Marketing, Dasan Networks | Min Woo Nam, CEO, Dasan Networks Inc3956K:KOE
00:10:00
Bob Nolan Discusses His Journey from Law to Private Equity and Growth Stage Investing
00:10:00
Today, CEO Eric Francia spoke to Bloomberg about the early retirement of ACEN's SLTEC coal plant and the rising demand for green energy solutions.
00:10:00
Mastering the Art of Macro Investment Strategies: A Deep Dive into Global Economic Trends | Peter Hébert, Co-founder, Lux Capital.
00:10:00
Unlocking the Gold Potential at Omai: A Former High-Grade Mine's Untapped Riches
00:10:00
Unlocking Prosperity: Joe Pantozzi on Infinite Banking and Wealth Building | Joe Pantozzi , President , Alpha Omega Wealth Management LLC.

© 2026 Nehu